Examkin

Soru

Zorluk: ZorInfection Control and Hospital-Acquired Conditions

A 29-year-old female healthcare worker is evaluated in the occupational health clinic after sustaining a deep percutaneous injury with a hollow-bore needle used to draw blood from a patient. The source patient is a 45-year-old man recently admitted with infective endocarditis associated with intravenous drug use. Rapid testing of the source patient's blood is positive for hepatitis B surface antigen (HBsAg), positive for hepatitis C antibody, and negative for HIV antibody. The healthcare worker provides official documentation showing she completed a standard 3-dose hepatitis B vaccination series 6 years ago. Her occupational health records from that time indicate a post-vaccination hepatitis B surface antibody (anti-HBs) titer of 42 mIU/mL. A baseline anti-HBs titer drawn from the healthcare worker today is reported as 6 mIU/mL. Which of the following is the most appropriate next step in the management of this healthcare worker regarding hepatitis B exposure?

  1. A
    Administer hepatitis B immune globulin and a booster dose of hepatitis B vaccine
  2. B
    Administer a booster dose of hepatitis B vaccine only
  3. C
    Administer hepatitis B immune globulin only
  4. Provide reassurance and no further hepatitis B prophylaxisCevap
  5. E
    Initiate a new 3-dose series of the hepatitis B vaccine

Cevap

Provide reassurance and no further hepatitis B prophylaxis
The correct answer is to provide reassurance and no further hepatitis B prophylaxis. According to CDC guidelines for occupational exposures, a healthcare worker who has documented completion of the hepatitis B vaccination series and a documented, adequate post-vaccination anti-HBs titer (≥ 10 mIU/mL) is considered an 'immune responder.' These individuals have permanent immunologic memory and do not require any post-exposure management for hepatitis B, even if their current anti-HBs titer has waned to < 10 mIU/mL and the source patient is definitively HBsAg positive. The memory B cells will rapidly produce neutralizing antibodies upon viral exposure, preventing clinical infection.

Adım Adım Çözüm

1
Determine the HBV status of the source patient.
The source patient is HBsAg positive, indicating active hepatitis B infection and a high risk of transmission.
The source's infectious status dictates the need for post-exposure prophylaxis.
2
Assess the prior immunity status of the exposed healthcare worker.
The healthcare worker has documentation of a complete vaccination series and a protective post-vaccination titer of 42 mIU/mL (which is ≥ 10 mIU/mL).
Documented prior response to the vaccine is the most critical factor in determining the need for post-exposure prophylaxis.
3
Evaluate the significance of the current anti-HBs titer of 6 mIU/mL.
The current titer is < 10 mIU/mL, but this is clinically irrelevant because intact immunological memory is present from her prior adequate response.
Circulating antibodies wane over time, but memory B cells will mount a rapid anamnestic response upon re-exposure.
4
Apply CDC post-exposure prophylaxis guidelines for a known responder.
No hepatitis B immune globulin (HBIG) or vaccine booster is indicated.
Known responders are considered fully protected against clinical infection and chronic carriage.

Anahtar Kavram

Healthcare workers with written documentation of a complete hepatitis B vaccine series and a subsequent post-vaccination anti-HBs titer of ≥ 10 mIU/mL are considered permanently immune and require no post-exposure prophylaxis, regardless of their current titer or the source patient's HBsAg status.
Tahmini Süre:1m 15s
Bu soruyu puanla

Konular

Infection Control and Hospital-Acquired Conditions

Bu konudan daha fazla soru